2007
DOI: 10.1016/j.jorganchem.2006.10.034
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 18 publications
(25 reference statements)
0
4
0
Order By: Relevance
“…Organo arsenic compounds despite their toxicity gets revived attention due to pharmaceutical use. [1][2][3][4] For example Carbarsone is an organoarsenic compound with antiprotozoal activity which is used against of the amebiasis. [5][6][7] They also are under consideration from the biological activity point of view yet.…”
Section: Introductionmentioning
confidence: 99%
“…Organo arsenic compounds despite their toxicity gets revived attention due to pharmaceutical use. [1][2][3][4] For example Carbarsone is an organoarsenic compound with antiprotozoal activity which is used against of the amebiasis. [5][6][7] They also are under consideration from the biological activity point of view yet.…”
Section: Introductionmentioning
confidence: 99%
“…A precise mechanism of action for Trisenox remains unknown and studies investigating the interaction of arsenic with biomolecules continue [25][26][27][28]. Patients suffering from acute promyelocytic leukaemia (AML) are characterized by an accumulation of immature granulocytes (i.e., promylelocytes: a category of white blood cells with granules in their cytoplasm) in their bone marrow.…”
Section: Arsenic Compoundsmentioning
confidence: 99%
“…Today, arsenic medicines have been largely replaced by less toxic compounds (Gorby, 1994), 6. However, arsenic compounds are still recognized as having beneficial uses in treating certain diseases, including some types of leukemia ( (Francesconi and Kuehnelt, 2004), 374; (Oremland and Stolz, 2003), 939;(Ben Zirar et al, 2007); Chapter 4). For example, As 2 O 3 is utilized to treat patients with acute promyelocytic leukemia (Zhu et al, 1999;Shen et al, 1997).…”
Section: Medicinal Applications: Dangerous Quackery and Some Importanmentioning
confidence: 99%